Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07573189 · ClinicalTrials.gov registry record · NA
The Effects of Recovery Compression Boots on Blood Lactate Levels, Functional Movement, and Joint Ange of Motion in Collegiate Athletes.
A NA study, sponsored by University of Redlands.
- Active
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT07573189: Active NA study, sponsored by University of Redlands.
NCT07573189 is a NA study that is active but no longer recruiting, run by University of Redlands. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07573189, a NA study, is active but no longer recruiting, sponsored by University of Redlands.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
This study aims to evaluate the use of intermittent compression boots (IPC) on post exercise recovery in collegiate athletes. Blood lactate will be analyzed (use of a finger prick) as a marker of physiological recovery. We will also analyze pre- and post-ankle range of motion using a handheld VALD DynaMo device to assess joint recovery and vertical jump performance using VALD ForceDecks to measure muscle readiness. These tests are widely used in sports science research but have not been measured collectively as a means to assess performance.
Primary Outcome
Countermovement Jump. A higher force production for the concentric portion of a CMJ is the desired outcome post intervention.
Interventions
- DEVICE Compression Boots
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2026-03-01 |
| Est. Completion | 2028-06 |
| Phase | NA |
What the registry record for NCT07573189 still lists
NCT07573189 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Compression Boots is the first listed.
NCT07573189 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07573189 about?
NCT07573189 is a clinical study titled "The Effects of Recovery Compression Boots on Blood Lactate Levels, Functional Movement, and Joint Ange of Motion in Collegiate Athletes.". This study aims to evaluate the use of intermittent compression boots (IPC) on post exercise recovery in collegiate athletes. Blood lactate will be analyzed (use of a finger prick) as a marker of physiological recovery. We will also analyze pre- and post-ankle range of motion using a handheld VALD D...
What is the current status of trial NCT07573189?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 38 participants. The study started on 2026-03-01. Estimated completion is 2028-06.
What interventions are being tested in trial NCT07573189?
The interventions under investigation include: Compression Boots (DEVICE).
Who is sponsoring clinical trial NCT07573189?
This trial is sponsored by University of Redlands, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07573189's enrollment target sits among peer trials
38 1538th of 2000 higher than 461 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI